Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo.

George J, Banik NL, Ray SK.

Neuro Oncol. 2010 Nov;12(11):1088-101. doi: 10.1093/neuonc/noq079. Epub 2010 Aug 2.

2.

Combination of taxol and Bcl-2 siRNA induces apoptosis in human glioblastoma cells and inhibits invasion, angiogenesis and tumour growth.

George J, Banik NL, Ray SK.

J Cell Mol Med. 2009 Oct;13(10):4205-18. doi: 10.1111/j.1582-4934.2008.00539.x.

3.

Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma.

Raguénez G, Mühlethaler-Mottet A, Meier R, Duros C, Bénard J, Gross N.

BMC Cancer. 2009 Mar 30;9:97. doi: 10.1186/1471-2407-9-97.

4.

N-(4-Hydroxyphenyl) retinamide induced both differentiation and apoptosis in human glioblastoma T98G and U87MG cells.

Das A, Banik NL, Ray SK.

Brain Res. 2008 Aug 28;1227:207-15. doi: 10.1016/j.brainres.2008.06.045. Epub 2008 Jun 21.

5.

Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.

Khan Z, Khan AA, Prasad GB, Khan N, Tiwari RP, Bisen PS.

Radiother Oncol. 2016 Feb;118(2):359-68. doi: 10.1016/j.radonc.2015.12.007. Epub 2015 Dec 30.

PMID:
26747757
6.
7.

Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.

Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.

Breast Cancer Res Treat. 2009 Sep;117(1):45-54. doi: 10.1007/s10549-008-0163-6. Epub 2008 Sep 13.

PMID:
18791823
8.

Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice.

Zhang R, Ma L, Zheng M, Ren J, Wang T, Meng Y, Zhao J, Jia L, Yao L, Han H, Li K, Yang A.

Cancer Gene Ther. 2010 Apr;17(4):275-88. doi: 10.1038/cgt.2009.68. Epub 2009 Oct 30.

PMID:
19876077
9.

Reactive Oxygen Species Mediates the Synergistic Activity of Fenretinide Combined with the Microtubule Inhibitor ABT-751 against Multidrug-Resistant Recurrent Neuroblastoma Xenografts.

Chen NE, Maldonado NV, Khankaldyyan V, Shimada H, Song MM, Maurer BJ, Reynolds CP.

Mol Cancer Ther. 2016 Nov;15(11):2653-2664. Epub 2016 Aug 16.

10.
11.

RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo.

Hendruschk S, Wiedemuth R, Aigner A, Töpfer K, Cartellieri M, Martin D, Kirsch M, Ikonomidou C, Schackert G, Temme A.

Neuro Oncol. 2011 Oct;13(10):1074-89. doi: 10.1093/neuonc/nor098. Epub 2011 Jul 25.

12.

Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.

Liu X, Gao R, Dong Y, Gao L, Zhao Y, Zhao L, Zhao X, Zhang H.

BMC Cancer. 2010 Aug 10;10:418. doi: 10.1186/1471-2407-10-418.

14.

Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice.

Shen X, Zheng JY, Shi H, Zhang Z, Wang WZ.

Am J Med Sci. 2012 Jul;344(1):52-8. doi: 10.1097/MAJ.0b013e318239c4ee.

PMID:
22261621
15.

Nonviral gene therapy in vivo with PAM-RG4/apoptin as a potential brain tumor therapeutic.

An S, Nam K, Choi S, Bai CZ, Lee Y, Park JS.

Int J Nanomedicine. 2013;8:821-34. doi: 10.2147/IJN.S39072. Epub 2013 Feb 25.

16.

Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids.

Bassani B, Bartolini D, Pagani A, Principi E, Zollo M, Noonan DM, Albini A, Bruno A.

PLoS One. 2016 Jul 1;11(7):e0154111. doi: 10.1371/journal.pone.0154111. eCollection 2016.

17.

Combined treatment of XIAP-targeting shRNA and celecoxib synergistically inhibits the tumor growth of non‑small cell lung cancer cells in vitro and in vivo.

Zhang H, Li Z, Wang K, Ren P.

Oncol Rep. 2015 Mar;33(3):1079-88. doi: 10.3892/or.2014.3678. Epub 2014 Dec 18.

PMID:
25524805
18.

Survivin knockdown increased anti-cancer effects of (-)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells.

Hossain MM, Banik NL, Ray SK.

Exp Cell Res. 2012 Aug 1;318(13):1597-610. doi: 10.1016/j.yexcr.2012.03.033. Epub 2012 Apr 10.

19.

Peptide micelle-mediated delivery of tissue-specific suicide gene and combined therapy with avastin in a glioblastoma model.

Oh B, Han J, Choi E, Tan X, Lee M.

J Pharm Sci. 2015 Apr;104(4):1461-9. doi: 10.1002/jps.24363. Epub 2015 Jan 28.

PMID:
25631673
20.

Downregulation of survivin by siRNA inhibits invasion and promotes apoptosis in neuroblastoma SH-SY5Y cells.

Zhang L, Liang H, Cao W, Xu R, Ju XL.

Braz J Med Biol Res. 2014 Jul;47(7):548-53. Epub 2014 May 23.

Supplemental Content

Support Center